IP Library Granted Patent US 7,227,016
Granted Patent B2
US 7,227,016 · App. 11/024,958 · Granted Jun 5, 2007

Process for the synthesis of oligomeric compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,227,016
App. No.
11/024,958
Granted
Jun 5, 2007
Kind
B2
Abstract

Synthetic processes are provided wherein oligomeric compounds are prepared having phosphodiester, phosphorothioate, phosphorodithioate, or other covalent linkages. The oligomers have substantially reduced exocyclic adducts deriving from acrylonitrile or related contaminants.

Claims (30)

1. A method of preparing a phosphorus-linked oilgonucleotide comprising:

providing a sample containing a plurality of oligonucleotides, said oligonucleotides linked to a solid support medium, said oligonucleotides comprising a plurality of nucleosides and a plurality of protected phosphorus linkages;

contacting said oligonucleotides with a deprotecting agent to remove phosphorus protecting groups from said oligonucleotides, wherein said oligonucleotides remain linked to said solid support medium during said contacting;

said deprotecting reagent comprising at least one secondary amine, the conjugate acid of said secondary amine having a pKa of from about 8 to about 11;

optionally washing said oligonucleotides; and

reacting said oligonucleotides with-a cleaving reagent, whereby the oligonucleotides are cleaved from the solid support medium.

2. The method of claim 1 , wherein the secondary amine is an aliphatic amine.

3. The method of claim 2 , wherein the aliphatic amine is (R) 2 NH, where R is alkyl.

4. The method of claim 3 , wherein R is ethyl.

5. The method of claim 1 , wherein at least one of the phosphorus protecting groups is a cyanoethyl protecting group.

6. The method of claim 1 , wherein at least one of said nucleosides has a 2'substituent group selected from O-alkyl or fluoro.

7. A method for deprotecting a phosphorus-linked oligonucleotide comprising a plurality of nucleosides and a plurality of protected phosphorus linkages of Formula II:

wherein:

each X is O or S;

R t is a phosphorus protecting group of formula:

—C(R 10 ) 2 —C(R 10 ) 2 —W or —C(R 10 ) 2 —(CH═CH) p —C(R 10 ) 2 —W

each R 10 is independently H or lower alkyl;

W is cyano;

p is 1 to 3

said oligonucleotides being linked to a solid support medium, the method comprising:

providing a plurality of said phosphorus-linked oligonucleotides;

contacting said oligonucleotides with a deprotecting reagent for a time and under conditions sufficient to remove said R t groups from said oligonucleotides, wherein said oligonucleotides remain linked to said solid support medium during said contacting;

said deprotecting reagent comprising at least one secondary amine, the conjugateacid of said secondary amine having a pKa of from about 8 to about 11; and

optionally washing said oligonucleotides;

reacting said oligonucleotides with a cleaving reagent, whereby the oligonucleotides are cleaved from the solid support medium.

8. The method of claim 7 , wherein R t is —CH 2 CH 2 —CN.

9. The method of claim 7 , wherein the secondary amine is an aliphatic amine.

10. The method of claim 9 , wherein the aliphatic amine is (R) 2 NH, where R is alkyl.

11. The method of claim 7 , wherein at least one of the phosphorus protecting groups is a cyanoethyl protecting group.

12. The method of claim 7 , wherein at least one of said nucleosides has a 2′-substiuent group selected from O-alkyl or fluoro.

Assignments (1)
CHANGE OF NAME Recorded Jul 26, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 043341/0891 →